Sharon D. Ricardo

6.9k total citations · 2 hit papers
109 papers, 5.5k citations indexed

About

Sharon D. Ricardo is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sharon D. Ricardo has authored 109 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 26 papers in Nephrology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sharon D. Ricardo's work include Renal and related cancers (34 papers), Chronic Kidney Disease and Diabetes (14 papers) and Genetic and Kidney Cyst Diseases (12 papers). Sharon D. Ricardo is often cited by papers focused on Renal and related cancers (34 papers), Chronic Kidney Disease and Diabetes (14 papers) and Genetic and Kidney Cyst Diseases (12 papers). Sharon D. Ricardo collaborates with scholars based in Australia, United States and Netherlands. Sharon D. Ricardo's co-authors include Harry van Goor, John F. Bertram, Allison A. Eddy, James A. Deane, Jonathan R. Diamond, Andrea F. Wise, Chrishan S. Samuel, Jinhua Li, Melissa H. Little and Christina V Jones and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and The Journal of Physiology.

In The Last Decade

Sharon D. Ricardo

104 papers receiving 5.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrophage diversity in renal injury and repair

2008 609 citations Sharon D. Ricardo et al. profile →
Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis

2016 320 citations Bo Wang, Brooke M. Huuskes et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon D. Ricardo Australia	40	2.5k	1.2k	931	917	806	109	5.5k
Hans J. Baelde Netherlands	41	1.8k 0.7×	1.5k 1.3×	483 0.5×	1.1k 1.2×	814 1.0×	160	5.8k
Emile de Heer Netherlands	47	2.9k 1.1×	2.6k 2.3×	1.1k 1.1×	1.3k 1.5×	1.1k 1.4×	204	8.5k
Jun‐ichi Hanai United States	30	4.0k 1.6×	590 0.5×	598 0.6×	901 1.0×	632 0.8×	40	6.9k
Michel Le Hir Switzerland	38	2.1k 0.8×	1.2k 1.0×	498 0.5×	1.2k 1.3×	625 0.8×	87	5.0k
Liliane J. Striker United States	48	2.2k 0.9×	2.1k 1.8×	828 0.9×	520 0.6×	456 0.6×	115	6.9k
Masayuki Iwano Japan	35	3.4k 1.3×	2.6k 2.3×	1.1k 1.2×	1.2k 1.3×	1.4k 1.7×	138	8.4k
Daniela Corna Italy	46	2.1k 0.8×	2.3k 2.0×	1.3k 1.4×	789 0.9×	686 0.9×	105	6.7k
Chunsun Dai China	52	4.1k 1.6×	2.8k 2.4×	1.2k 1.3×	767 0.8×	962 1.2×	119	8.0k
Simon C. Satchell United Kingdom	42	1.8k 0.7×	2.5k 2.1×	760 0.8×	1.1k 1.2×	671 0.8×	110	6.1k
Mauro Abbate Italy	48	2.3k 0.9×	3.0k 2.6×	1.6k 1.7×	881 1.0×	890 1.1×	116	7.2k

Countries citing papers authored by Sharon D. Ricardo

Since Specialization

Citations

This map shows the geographic impact of Sharon D. Ricardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon D. Ricardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon D. Ricardo more than expected).

Fields of papers citing papers by Sharon D. Ricardo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon D. Ricardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon D. Ricardo. The network helps show where Sharon D. Ricardo may publish in the future.

Co-authorship network of co-authors of Sharon D. Ricardo

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon D. Ricardo. A scholar is included among the top collaborators of Sharon D. Ricardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon D. Ricardo. Sharon D. Ricardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baghaei, Kaveh, et al.. (2025). Single‐Cell Fluorescence Imaging Reveals Heterogeneity in Senescence Biomarkers and Identifies Rapamycin‐Responsive Sub‐Populations. Aging Cell. 24(10). e70209–e70209.

Li, Yifang, Guizhi Sun, Ricky W.K. Lau, et al.. (2024). The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo. Stem Cell Research & Therapy. 15(1). 375–375.

Wise, Andrea F., Andrew J. Kassianos, Sheetal Saini, et al.. (2024). Fabry Disease Podocytes Reveal Ferroptosis as a Potential Regulator of Cell Pathology. Kidney International Reports. 10(2). 535–548. 2 indexed citations

Huurne, Menno ter, Benjamin L. Parker, Ning Qing Liu, et al.. (2023). GLA-modified RNA treatment lowers GB3 levels in iPSC-derived cardiomyocytes from Fabry-affected individuals. The American Journal of Human Genetics. 110(9). 1600–1605. 6 indexed citations

Ding, Chenguang, Bo Wang, Greg H. Tesch, et al.. (2023). Cellular delivery of relaxin-2 mRNA as a potential treatment for kidney fibrosis. Materials Today Bio. 21. 100716–100716. 5 indexed citations

Kulkarni, Ketav, et al.. (2023). A comparison of fixation methods for SEM analysis of self-assembling peptide hydrogel nanoarchitecture. Nanoscale. 15(3). 1431–1440. 10 indexed citations

Chakraborty, Amlan, Hannah E. J. Yong, Sheetal Saini, et al.. (2022). The Placental NLRP3 Inflammasome and Its Downstream Targets, Caspase-1 and Interleukin-6, Are Increased in Human Fetal Growth Restriction: Implications for Aberrant Inflammation-Induced Trophoblast Dysfunction. Cells. 11(9). 1413–1413. 22 indexed citations

Wang, Bo, Chenguang Ding, Xiaoming Ding, et al.. (2021). WNT1-inducible signaling pathway protein 1 regulates kidney inflammation through the NF-κB pathway. Clinical Science. 136(1). 29–44. 10 indexed citations

Yong, Hannah E. J., Shiao‐Yng Chan, Amlan Chakraborty, et al.. (2021). Significance of the placental barrier in antenatal viral infections. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(12). 166244–166244. 20 indexed citations

10.

Wang, Bo, Guanyu Ji, Haroon Naeem, et al.. (2018). The Use of Targeted Next Generation Sequencing to Explore Candidate Regulators of TGF-β1’s Impact on Kidney Cells. Frontiers in Physiology. 9. 1755–1755. 11 indexed citations

11.

Polglase, Graeme R., Beth J. Allison, Tamara Yawno, et al.. (2017). Effects of antenatal melatonin therapy on lung structure in growth-restricted newborn lambs. Journal of Applied Physiology. 123(5). 1195–1203. 20 indexed citations

12.

Wang, Bo, Brooke M. Huuskes, Hsin‐Hui Shen, et al.. (2016). Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis. Molecular Therapy. 24(7). 1290–1301. 320 indexed citations breakdown →

13.

Ricardo, Sharon D.. (2011). Regenerative Nephrology. Hardcover. Nephrology. 16(4). 455–455.

14.

Lin, Shu-An, Gabriel Kolle, Sean M. Grimmond, et al.. (2010). Subfractionation of Differentiating Human Embryonic Stem Cell Populations Allows the Isolation of a Mesodermal Population Enriched for Intermediate Mesoderm and Putative Renal Progenitors. Stem Cells and Development. 19(10). 1637–1648. 39 indexed citations

15.

Li, Jinhua, James A. Deane, Naomi Campanale, John F. Bertram, & Sharon D. Ricardo. (2006). The Contribution of Bone Marrow-Derived Cells to the Development of Renal Interstitial Fibrosis. Stem Cells. 25(3). 697–706. 96 indexed citations

16.

Loveland, Kate L., et al.. (2006). Modulation and Redistribution of Proteinase Inhibitor 8 (Serpinb8) during Kidney Regeneration. American Journal of Nephrology. 26(1). 34–42. 9 indexed citations

17.

Ricardo, Sharon D. & James A. Deane. (2005). Adult stem cells in renal injury and repair (Review Article). Nephrology. 10(3). 276–282. 32 indexed citations

18.

Cowley, Benjamin D., Sharon D. Ricardo, Shizuko Nagao, & Jonathan R. Diamond. (2001). Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney International. 60(6). 2087–2096. 85 indexed citations

19.

Diamond, Jonathan R., Sharon D. Ricardo, & Saulo Klahr. (1998). Mechanisms of interstitial fibrosis in obstructive nephropathy.. PubMed. 18(6). 594–602. 70 indexed citations

20.

Ricardo, Sharon D., John F. Bertram, & G.B. Ryan. (1994). Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.. Journal of the American Society of Nephrology. 4(12). 1974–1986. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact